Evidence map›Paper›PMID 29844495›Full record

ArticleNature communications2018

Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR.

Yaxin Dai, Aili Zhang, Shan Shan, Zihua Gong, Zheng Zhou

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yaxin DaiNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Aili ZhangDepartment of Cancer Biology, Cleveland Clinic Lerner Research Institute, Cleveland, 44195, OH, USA.
Shan ShanNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Zihua GongDepartment of Cancer Biology, Cleveland Clinic Lerner Research Institute, Cleveland, 44195, OH, USA. gongz@ccf.org.
Zheng ZhouNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. zhouzh@sun5.ibp.ac.cn.
Cleveland Clinic Lerner College of Medicine · USUniversity of Chinese Academy of Sciences · CNInstitute of Biophysics · CN

Funding

The role of NUDT16 in DNA damage response and tumorigenesisR01CA222195 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Zihua Gong · 2019 to 2026
$3.8M
Targeting the DNA repair pathway choice in breast cancer treatmentR21CA192052 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GONG, ZIHUA · 2015 to 2016
$381k
NCI NIH HHS R01 CA222195NCI NIH HHS R21 CA192052
6 · The paper itself

Abstract

P53-binding protein 1 (53BP1) regulates the double-strand break (DSB) repair pathway choice. A recently identified 53BP1-binding protein Tudor-interacting repair regulator (TIRR) modulates the access of 53BP1 to DSBs by masking the H4K20me2 binding surface on 53BP1, but the underlying mechanism remains unclear. Here we report the 1.76-Å crystal structure of TIRR in complex with 53BP1 tandem Tudor domain. We demonstrate that the N-terminal region (residues 10-24) and the L8-loop of TIRR interact with 53BP1 Tudor through three loops (L1, L3, and L1'). TIRR recognition blocks H4K20me2 binding to 53BP1 Tudor and modulates 53BP1 functions in vivo. Structure comparisons identify a TIRR histidine (H106) that is absent from the TIRR homolog Nudt16, but essential for 53BP1 Tudor binding. Remarkably, mutations mimicking TIRR binding modules restore the disrupted binding of Nudt16-53BP1 Tudor. Our studies elucidate the mechanism by which TIRR recognizes 53BP1 Tudor and functions as a cellular inhibitor of the histone methyl-lysine readers.

Indexed as

AnimalsBinding SitesCarrier ProteinsCell Line, TumorCrystallography, X-RayDNA Breaks, Double-StrandedDNA RepairHEK293 CellsHumansMiceProtein BindingProtein Structure, TertiaryRNA-Binding ProteinsTudor DomainTumor Suppressor p53-Binding Protein 1Carrier ProteinsNUDT16L1 protein, humanRNA-Binding ProteinsTP53BP1 protein, humanTrp53bp1 protein, mouseTumor Suppressor p53-Binding Protein 1

Identifiers

PMID29844495
PMCPMC5974088
OpenAlexW2807198260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.